Zepharma Inc. said Wednesday it is recalling 27,419 bottles of its AG Nose anti-allergy nasal spray after a higher level of bacteria than standard was detected.
Subject to the recall are 10- and 20-milliliter bottles shipped since March, the Tokyo-based drug maker said.
The drug, which relieves symptoms associated with pollen and dust allergies, is sold over the counter.
Zepharma said it has found the Burkholderia cepacia bacteria in an AG Nose bottle at Hoshienu Pharmaceutical Co., which manufactures the drug under contract for Zepharma, exceeded the standard level.
The bacteria, although unlikely to pose serious problems, can cause a fever in people with suppressed immunity, the company said.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.